Candriam Eqs L Biotech R GBP Cap
Asset allocation %
Morningstar style box TM
Equity style
SizeLarge
Mid
Small
Value
Blend
Growth
Style
Size
| Share class size (mil) | 2 GBP (16/11/2026) |
| Fund size (mil) | 1,449 GBP (16/11/2026) |
Top 10 holdings
| Assets in top 10 holdings % | 33.90 |
| Total number of equity holdings | 74 |
| Total number of bond holdings | 0 |
| Holdings 30/04/2026 | % of assets |
|---|---|
| Vertex Pharmaceuticals Inc | 4.07 |
| Gilead Sciences Inc | 3.99 |
| Alnylam Pharmaceuticals Inc | 3.90 |
| Amgen Inc | 3.81 |
| Regeneron Pharmaceuticals Inc | 3.54 |
| Biogen Inc | 3.46 |
| Insmed Inc | 3.07 |
| Revolution Medicines Inc Ordinary Shares | 2.91 |
| Roivant Sciences Ltd Ordinary Shares | 2.81 |
| Ascendis Pharma AS | 2.32 |